Pulmonary absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) after intratracheal administration to rats

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 2, 1996, Pages 259-262

  Machida, Minoru ^a   Hayashi, Masahiro ^b   Awazu, Shoji ^c  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

intratracheal administration; pharmacological availability; pulmonary absorption; relative bioavailability; rhG CSF; total leukocyte number

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; INTRANASAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; LUNG CLEARANCE; MALE; NEUTROPENIA; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029980680     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.259     Document Type: Article

References (15)

1. Nagata S., Tsuchiya M., Asano S., Yamamoto O., Hirata Y., Kubota N., Oheda M., Nomura H , Yamazaki T., EMBO J., 5, 575 (1986).
2. Nagata S., Tsuchiya M., Asano S., Kaziro Y., Yamazaki T., Yamamoto O., Hirai Y., Kubota N., Oheda M , Nomura H., Ono M., Nature (London), 319, 415 (1986).
3. Hirai S., Yashiki T., Mima H., Int. J. Pharmaceut., 9, 165 (1981).
4. IshidaM., Machida Y., Nambu N., Nagai T , Chem. Pharm. Bull., 29, 810 (1981).
5. Nishihata T., Rytting J. H , Kamada A., Higuchi T., Routh M., Caldwell L., J. Pharm. Pharmacol., 35, 148 (1983).
6. Yamamoto A., Luo A M., Dodda-Kashi S., Lee V. H., J. Pharmacol Exp Ther., 249, 249 (1989).
7. Machida M., Sano K., Arakawa M., Hayashi M., Awazu S., Pharm. Res., 10, 1372 (1993).
8. Machida M., Sano K., Arakawa M., Hayashi M., Awazu S., Biol. Pharm. Bull., 17, 1375 (1994).
9. Niven R. W., Lott F. D., Cribbs J. M., Pharm. Res., 10, 1604 (1993).
10. Nissen C., Carbonare V. D., Moser Y., Drug Invest., 7, 346 (1994).
11. Enna S. J., Schanker L. S., Am. J. Physiol., 222, 409 (1972).
12. Motojima H., Kobayashi T., Shimane M., Kamachi S., Fukushima M., J. Immunol. Methods, 118, 187 (1989).
13. Wigley F. M., Londono J. H., Wood S. H., Shipp J. C., Waldman R. H., Diabetes, 20, 552 (1971).
14. Yoshida H., Okumura K., Hori K., Anmo T., Yamaguchi H., J. Pharm. Sci., 68, 670 (1979).
15. Monta T., Yamamoto A., Hashida M., Sezaki H., Biol. Pharm. Bull., 16, 259 (1993).